Printer Friendly

CYTOCARE INC. ELECTS NEW DIRECTOR

 CYTOCARE INC. ELECTS NEW DIRECTOR
 IRVINE, Calif., May 11 /PRNewswire/ -- Cytocare Inc. (NASDAQ: CYTI),


announced today that Ivor Royston, M.D., has been elected to its board of directors. Royston is the president and scientific director of the San Diego Regional Cancer Center and an adjunct professor of medicine at the University of California, San Diego (UCSD). From 1983-1990, Royston was director of the Clinical Immunology Program of the UCSD Cancer Center. Royston was a co-founder and director of Hybritech. Royston received his doctor of medicine degree from Johns Hopkins University and completed post-doctoral training at Stanford University leading to board certifications in both internal medicine and medical oncology.
 Cytocare Inc. is developing a family of diagnostic and therapeutic pharmaceuticals and devices for prostate disease. Medstone International Inc., its manufacturing subsidiary, serves urology with lithotripsy products and procedures.
 -0- 5/11/92
 /CONTACT: Jeannine Cormane of Cytocare, 714-587-0500/
 (CYTI) CO: Cytocare Inc. ST: California IN: MTC SU: PER


AL-JL -- LA008 -- 8451 05/11/92 09:07 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 11, 1992
Words:167
Previous Article:CB COMMERCIAL REAL ESTATE GROUP RELEASES FIRST QUARTER 1992 COMMERCIAL VACANCY RATES
Next Article:CYTOCARE FILES 510(k) SUBMISSION FOR LASER CATHETER FOR LASER SURGERY OF UROLOGICAL TISSUES
Topics:


Related Articles
CYTOCARE BUYS RIGHTS TO PROSTATE CANCER ANTIBODIES
PFIZER ANNOUNCES EXECUTIVE APPOINTMENTS.
CYTOCARE, INC. REPORTS YEAR-END RESULTS
CYTOCARE REPORTS FIRST QUARTER RESULTS
CARDIAC SCIENCE INC. LIFTS THE RESTRICTION ON TRANSFER OF SHARES AND RAISES ADDITIONAL FUNDS
CYTOCARE ANNOUNCES LITIGATION VICTORY
CYTOCARE FILES 510(k) SUBMISSION FOR LASER CATHETER FOR LASER SURGERY OF UROLOGICAL TISSUES
Primus Innovations and Health Robotics Launch Strategic Partnership to Accelerate Transformation in Chemotherapy Compounding.
Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters